You are viewing: Argentina Oligonucleotide Synthesis Market analysis

The Argentina Oligonucleotide Synthesis Market was valued at $23.3 Million in 2025 and projected to reach to $49.2 Million by 2030, representing a compound annual growth rate of 16.1%. Argentina's oligonucleotide synthesis market is positioned for significant growth, driven by expanding genomic research initiatives and the country's commitment to advancing its biotechnology sector.

Argentina Oligonucleotide Synthesis Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Argentina Oligonucleotide Synthesis Market Trends and Insights

  • This 16.1% compound annual growth rate reflects Argentina's strengthening position in Latin America's biotechnology and pharmaceutical sectors.
  • Argentina's investment in genomic research, coupled with rising demand for personalized medicine and gene therapy applications, is driving market acceleration across the forecast period. The oligonucleotide synthesis landscape in Argentina is characterized by increasing adoption of synthetic biology platforms and therapeutic development initiatives.
  • Argentina's growing research infrastructure and collaborations with international biotech firms are enhancing local manufacturing capabilities and innovation pipelines.
  • By 2030, Argentina is expected to consolidate its role as a regional hub for oligonucleotide-based therapeutics, supported by favorable regulatory frameworks and expanding clinical trial activity. Argentina's market growth is underpinned by rising healthcare expenditure, academic research funding, and private sector investment in molecular diagnostics and RNA therapeutics.
  • The country's skilled workforce and cost-competitive manufacturing environment position Argentina competitively within Latin America's oligonucleotide synthesis ecosystem..

Key Market Statistics

  • CAGR (2025-2030) 16.1% CAGR
  • Market Size, 2025 ~USD 23.3 Million
  • Forecast, 2030 ~USD 49.2 Million
  • Country Argentina

Argentina Oligonucleotide Synthesis Market Overview

Market Valuation Growth :

Argentina's oligonucleotide synthesis market is valued at $23.3 million in 2025, with projections reaching $49.2 million by 2030, representing a 16.1% CAGR over the forecast period.

Genomic Research Investment :

Argentina is strengthening its position in Latin America's biotechnology sector through increased government and private investment in genomic research infrastructure and capabilities.

Personalized Medicine Demand :

Rising adoption of personalized medicine approaches in Argentina's healthcare system is driving demand for oligonucleotide synthesis technologies and custom therapeutic solutions.

Regional Biotechnology Hub :

Argentina is emerging as a key biotechnology hub in Latin America, attracting pharmaceutical companies and research institutions seeking oligonucleotide synthesis capabilities for drug development.

Argentina Oligonucleotide Synthesis Market Dynamics

  • The 16.1% CAGR reflects increasing adoption of oligonucleotide-based therapeutics and diagnostic applications across Argentine healthcare institutions. The market outlook is supported by growing investments in precision medicine, strengthening regulatory frameworks for biopharmaceuticals, and collaboration between academic institutions and pharmaceutical companies.
  • Argentina's strategic location in South America and skilled scientific workforce position it as an attractive destination for oligonucleotide synthesis manufacturing and research activities..

Related Ecosystem

Biotechnology

Top Technologies
    Top Companies

      Key Takeaways

      • Argentina's oligonucleotide synthesis market will nearly double from $23.3M (2025) to $49.2M (2030), driven by 16.1% CAGR.
      • Argentina is emerging as a regional biotech hub with expanding research infrastructure and international collaborations in gene therapy and RNA therapeutics.
      • Argentina's cost-competitive manufacturing and skilled workforce position the country as an attractive hub for oligonucleotide production within Latin America.
      • Rising healthcare investment and personalized medicine adoption in Argentina are accelerating demand for oligonucleotide-based diagnostics and therapeutics.

      Oligonucleotide Synthesis Market Report Scope

      Report Metric Details
      Base Year 2025
      Forecast Period 2025–2030
      Growth Rate CAGR of 18.6% from 2025 to 2030
      Market Size Base Year (Billions) ~USD 10.53 (2025)
      Revenue Forecast (Billions) ~USD 24.7 (2030)
      Segments Covered Product, Type, Application, Disease Type, End User

      Argentina Oligonucleotide Synthesis Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Product

      • Dna Oligos
      • Equipment
      • Oligonucleotide-Based Drugs
      • Other Synthesized Oligos
      • Primers
      • Probes
      • Reagents & Consumables
      • Rna Oligos
      • Synthesized Oligonucleotides

      By Type

      • Antisense Oligonucleotide-Based-Drugs
      • Custom Oligonucleotides
      • Other Oligonucleotide-Based-Drugs
      • Other Research Applications
      • Pcr
      • Predesigned Oligonucleotides
      • Sequencing
      • Sirna Oligonucleotide-Based-Drugs

      By Application

      • Diagnostic Applications
      • Research Applications
      • Therapeutic Applications

      By Disease Type

      • Neurological Disorders
      • Other Diseases
      • Rare Diseases

      By End User

      • Academic Research Institutes
      • Cros & Cmos
      • Diagnostic Laboratories
      • Hospitals
      • Pharmaceutical & Biotechnology Companies

      Target Audience

      • Pharmaceutical Companies : Pharmaceutical manufacturers seeking to expand oligonucleotide synthesis capabilities in Argentina or establish regional manufacturing hubs for Latin American distribution.
      • Biotechnology Firms : Biotech companies developing oligonucleotide-based therapeutics and diagnostics requiring market intelligence on Argentina's growth potential and customer base.
      • Research Institutions : Academic and research organizations in Argentina needing market data to support funding proposals, collaboration initiatives, and genomic research program development.
      • Investment & Private Equity : Investors and PE firms evaluating opportunities in Argentina's biotechnology sector and oligonucleotide synthesis market for portfolio expansion and capital allocation.
      • Healthcare Providers & Diagnostics : Argentine hospitals, diagnostic centers, and healthcare systems seeking to understand oligonucleotide-based diagnostic and therapeutic options for patient care advancement.

      Key Companies in the Argentina Oligonucleotide Synthesis Market

      CompanyHQOwnershipStrongest segments
      FLUOR CORPORATIONUnited StatesPublic CompanyEnergy Solutions (oil, gas, chemicals, LNG, power, energy transition),Urban Solutions (advanced technologies, life sciences, mining, infrastructure, staffing, maintenance),Mission Solutions (government, nuclear remediation, security, logistics, O&M),

      FLUOR CORPORATION

      Fluor Corporation is a publicly traded engineering and construction company founded in 1912 and headquartered in the United States. With approximately 23,000 employees, the company provides design, engineering, procurement, and construction services across multiple industries.

      Reasons to Buy this Report

      • Market Entry Strategy : Gain detailed insights into Argentina's oligonucleotide synthesis market dynamics to develop targeted market entry strategies and identify partnership opportunities with local biotechnology firms.
      • Competitive Positioning : Understand Argentina's competitive landscape, key players, and market gaps to position your oligonucleotide synthesis solutions effectively within the growing Latin American market.
      • Investment Decision Support : Access comprehensive market data and forecasts to support investment decisions in Argentina's biotechnology sector, including facility expansion and R&D initiatives.
      • Regulatory & Compliance Insights : Obtain Argentina-specific regulatory requirements, approval pathways, and compliance standards for oligonucleotide synthesis products and manufacturing operations.
      • Growth Opportunity Identification : Identify high-growth segments within Argentina's oligonucleotide market, including personalized medicine applications, diagnostic development, and therapeutic innovation areas.

      Frequently asked questions

      What is the current size of Argentina's oligonucleotide synthesis market?

      Argentina's oligonucleotide synthesis market was valued at $23.3 million in 2025 and is projected to grow to $49.2 million by 2030.

      What is the expected growth rate for Argentina's oligonucleotide synthesis market?

      Argentina's oligonucleotide synthesis market is expected to grow at a compound annual growth rate (CAGR) of 16.1% from 2025 to 2030.

      What factors are driving growth in Argentina's oligonucleotide synthesis market?

      Key drivers include increased investment in genomic research, rising demand for personalized medicine and gene therapy, expanding research infrastructure, and growing clinical trial activity in Argentina.

      How does Argentina's oligonucleotide synthesis market compare to the global market?

      Argentina's market CAGR of 16.1% is slightly below the global CAGR of 18.6%, reflecting Argentina's strong but moderately paced regional growth trajectory within Latin America.

      What competitive advantages does Argentina offer in oligonucleotide synthesis?

      Argentina offers cost-competitive manufacturing, a skilled scientific workforce, favorable regulatory frameworks, and strategic positioning as a regional biotech hub with growing international collaborations.

      RESEARCH METHODOLOGY

      This research study extensively used secondary sources, directories, and databases to identify and collect valuable information for analyzing the global oligonucleotide synthesis market. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

      Secondary Research

      Secondary research was used primarily to identify and collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include annual reports, SEC filings, investor presentations, the World Health Organization (WHO), the United States Food and Drug Administration (US FDA), the National Center for Biotechnology Information (NCBI), and regulatory body websites, among others. These sources also provided key information on major players, market classification and segmentation aligned with industry trends, regional and country-level markets, market developments, and technology perspectives.

      Primary Research

      In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess the market's prospects. Primary sources from both the supply and demand sides of the market were interviewed to gather qualitative and quantitative information. The following is a breakdown of the primary respondents:

      Oligonucleotide Synthesis Market Size, and Share

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the oligonucleotide synthesis market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:

      Oligonucleotide Synthesis Market : Top-Down and Bottom-Up Approach

      Oligonucleotide Synthesis Market Top Down and Bottom Up Approach

      Data Triangulation

      After determining the overall market size through the estimation process, the total market was segmented into several segments and subsegments. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.

      Market Definition

      Oligonucleotide synthesis is the chemical process of creating nucleic acid fragments with specific chemical structures or sequences, of varying sizes, to form a desired product. These fragments, known as oligonucleotides, have several applications in medical and life science research. They can be used for DNA sequencing and amplification, detecting complementary DNA or RNA through hybridization, creating artificial genes, and introducing targeted genetic mutations.

      Oligonucleotides are also used to develop therapeutic drugs. These drugs are chemically synthesized and have different mechanisms of action, such as interfering with gene expression, blocking the production of harmful proteins, or restoring the function of mutated genes.

      Key Stakeholders

      • Pharmaceutical & biotechnology companies
      • Hospitals
      • Diagnostic laboratories
      • Academic researchers and government research organizations
      • Private research institutes
      • Custom oligonucleotide service providers
      • Contract manufacturing organizations (CMOs)
      • Oligonucleotide equipment manufacturers
      • Contract research organizations (CROs)
      • Market research & consulting firms
      • Venture capitalists

      Report Objectives

      • To define, describe, and forecast the global oligonucleotide synthesis market based on the offering, type, application, end user, therapeutic area, and region
      • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, and opportunities)
      • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall oligonucleotide synthesis market
      • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of the market segments with respect to six regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
      • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
      • To analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the oligonucleotide synthesis market
      • To provide information on funding & investment activities, brand/product comparative analysis, vendor valuation, and financial metrics of the oligonucleotide synthesis market

      Available customizations:

      With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for this report:

      Portfolio Assessment

      • Product Matrix gives a detailed comparison of the product portfolios of the top five companies.

      Geographical Analysis

      • A further breakdown of the Rest of Europe’s oligonucleotide synthesis market into countries
      • A further breakdown of the Rest of Asia Pacific’s oligonucleotide synthesis market into countries
      • A further breakdown of the Rest of Latin America’s oligonucleotide synthesis market into countries
      • A further breakdown of the Rest of Middle East’s oligonucleotide synthesis market into countries

      Company Information

      • Detailed analysis and profiling of additional market players (up to five).

       

      Get the Full Oligonucleotide Synthesis Market Report

      Full forecast, segment splits, and company analysis for all Oligonucleotide Synthesis Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status